
GLP-1 drugs like Ozempic are usually discussed as weight-loss medicines. But in October 2025, a testing company announced that semaglutide had reversed biological age by 3.1 years, and in 2026, a study in Nature reported that old female mice given the drug lived longer. The story of these drugs began with a gut hormone the body destroys in about two minutes, a lizard venom, and heart safety trials that were never meant to find a benefit. This investigation follows that evidence from the original discovery to the latest human trials to determine what GLP-1 drugs actually do, and whether their reputation as longevity drugs has been earned.
TIMESTAMPS
0:00 Intro
0:48 The two-minute hormone
1:33 The Gila monster discovery
2:29 The heart safety scare
4:02 Ozempic becomes a weight-loss drug
4:42 The SELECT and FLOW trials
6:13 Where the 3.1 years came from
7:48 The Alzheimer's trials
8:56 Old mice lived longer
10:22 What happens when people stop
11:34 What the evidence actually shows
Altri episodi di "The Active Site"



Non perdere nemmeno un episodio di “The Active Site”. Iscriviti all'app gratuita GetPodcast.








